Enrique Poradosu
Founder at NUVECTIS PHARMA, INC.
Net worth: 10 M $ as of 31/05/2024
Network origin in Enrique Poradosu first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 35 | |
| Subsidiary | Pharmaceuticals: Major | 13 | |
| Public Company | Pharmaceuticals: Major | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Enrique Poradosu via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Chief Executive Officer Director of Finance/CFO Director/Board Member Director/Board Member | |
Lirum Therapeutics, Inc.
 Lirum Therapeutics, Inc. BiotechnologyHealth Technology Lirum Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the treatment of deliberating diseases. The firm is also involved in the acquisition, development, and commercialization of drug candidates. Its products include LX-101, a targeted therapy directed to the insulin-like growth factor 1 (IGF-1R). The company was founded in November 2021 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| XTL BIOPHARMACEUTICALS LTD. | Medical Specialties | Director/Board Member Chairman Chief Executive Officer Director of Finance/CFO | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Investor Relations Contact Corporate Officer/Principal General Counsel | |
| CHECKPOINT THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer Director of Finance/CFO | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Ithaca College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
ACCESS Oncology, Inc.
 ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Part of Akebia Therapeutics, Inc., ACCESS Oncology, Inc. is a company that develops pharmaceutical drugs. The company is based in New York, NY. The company was founded by Michael Sean Weiss. ACCESS Oncology was acquired by Keryx Biopharmaceuticals, Inc., part of Akebia Therapeutics, Inc. from December 13, 2018 on February 06, 2004 for $36.44 million. | Pharmaceuticals: Other | Chief Executive Officer President Director of Finance/CFO | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Opus Point Partners Management LLC
 Opus Point Partners Management LLC Investment ManagersFinance Opus Point Partners Management LLC (OPPM) is a hedge fund manager headquartered in New York City. The firm was founded by Lindsay Rosenwald and Michael Weiss in 2009. They are owned by Opus Point Partners LLC, which is a subsidiary of Weiss & Co. LLC. OPPM manages investments that are dedicated to healthcare and life science. | Investment Managers | Chief Executive Officer Founder Director of Finance/CFO | |
| DYADIC INTERNATIONAL, INC. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Pharmaceuticals: Major | Chief Executive Officer President | |
| MESOBLAST LIMITED | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Columbia Law School | College/University | Graduate Degree Graduate Degree | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| The Hebrew University of Jerusalem | College/University | Undergraduate Degree Doctorate Degree | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin | |
| NATIONAL HOLDINGS CORPORATION | Investment Banks/Brokers | Chairman Director/Board Member | |
| UNIQURE N.V. | Biotechnology | Director/Board Member Director/Board Member | |
| University of Michigan | College/University | Undergraduate Degree Undergraduate Degree | |
| ALAUNOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Bar-Ilan University | College/University | Masters Business Admin Graduate Degree | |
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| SEAGEN INC. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal | |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Siena College | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree | |
Kidney Care Partners
 Kidney Care Partners Medical/Nursing ServicesHealth Services Kidney Care Partners provides healthcare services. It specializes in patient survival, hospitalization and patient experience with care. The company was founded in May 2003 and is headquartered in Washington, DC. | Medical/Nursing Services | Chairman Director/Board Member | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Masters Business Admin | |
| Emory University | College/University | Graduate Degree Corporate Officer/Principal | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer Investor Relations Contact | |
Helocyte, Inc.
 Helocyte, Inc. Miscellaneous Commercial ServicesCommercial Services Helocyte, Inc. engages in the development and commercialization of immunotherapies for the prevention and treatment of cytomegalovirus or CMV (cancer and infectious disease). It focuses on developing PepVax, a HLA-restricted single antigen peptide vaccine for controlling CMV in allogeneic hematopoietic stem cell transplant recipients and Triplex. The company was founded by Donald J. Diamond in 2015 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Founder Director/Board Member | |
American Kidney Fund, Inc.
 American Kidney Fund, Inc. Medical/Nursing ServicesHealth Services The American Kidney Fund provides treatment and financial assistance to patients with chronic kidney disease. It also provides assistance with expenses that insurance will not cover, such as transportation to dialysis, medications, special diet, kidney donor expenses, and other treatments. It also conducts specialty programs that help patients afford treatment during emergency travel and recover from natural disasters. The company was founded in 1971, and is headquartered in Rockville, MD. | Medical/Nursing Services | Chairman Director/Board Member | |
| ORIGO ACQUISITION CORP | Financial Conglomerates | Chief Executive Officer Chairman | |
| Cellvation, Inc. | Chairman Director/Board Member | ||
| State University of New York at Albany | College/University | Undergraduate Degree Undergraduate Degree | |
| Baruch College | College/University | Masters Business Admin Undergraduate Degree | |
Caelum Biosciences, Inc.
 Caelum Biosciences, Inc. BiotechnologyHealth Technology Caelum Biosciences, Inc. operates as a clinical-stage biotechnology company developing treatments for rare and life-threatening diseases. The company was founded in January 2017 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
Cyprium Therapeutics, Inc.
 Cyprium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Fortress Biotech, Inc., Cyprium Therapeutics, Inc. is an American New York-based company focused on developing novel therapies for the treatment of Menkes disease and related copper metabolism disorders. The company was granted FDA breakthrough therapy, fast track, and rare pediatric disease designations, as well as FDA orphan drug designation for both Cutx-101 and AAV-ATP7A. The European Medicines Agency also granted orphan drug designation to Cyprium. In March 2017, Cyprium entered into a cooperative research and development agreement with the Eunice Kennedy Shriver National Institute of Child Health and Human Development to advance the clinical development of Cutx-101 for the treatment of Menkes disease. In 2023, Cyprium completed the transfer of its proprietary rights and assigned its FDA documents pertaining to Cutx-101 to Sentynl Therapeutics, Inc. Cyprium and NICHD also previously entered into a worldwide, exclusive license agreement to develop and commercialize AAV-ATP7A gene therapy, which is currently in pre-clinical development. The company was founded in 2017 by Michael Sean Weiss, Lindsay Allan Rosenwald, and Lung S. Yam, who has been the CEO since then. | Miscellaneous Commercial Services | Founder Founder | |
Baergic Bio, Inc.
 Baergic Bio, Inc. Pharmaceuticals: MajorHealth Technology Baergic Bio, Inc. develops therapeutic drugs for the treatment of central nervous system disorders. It offers oncology, rare diseases, and gene therapy. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| FORTRESS BIOTECH, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| MUSTANG BIO, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| IMMUNOMEDICS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| AVENUE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistics
International
| United States | 45 |
| Israel | 4 |
| Netherlands | 3 |
| Australia | 2 |
Sectoral
| Health Technology | 27 |
| Consumer Services | 14 |
| Commercial Services | 5 |
| Finance | 4 |
| Health Services | 4 |
Operational
| Director/Board Member | 191 |
| Corporate Officer/Principal | 89 |
| Independent Dir/Board Member | 67 |
| Director of Finance/CFO | 55 |
| Undergraduate Degree | 47 |
Most connected contacts
| Insiders | |
|---|---|
| Uri Ben-Or | 31 |
| J. Buchi | 26 |
| Michael Weiss | 25 |
| Ronald Renaud | 24 |
| Lindsay Rosenwald | 23 |
| Joseph Feczko | 23 |
| Eric Rose | 21 |
| Kevin Cameron | 17 |
| BILL Kessler | 16 |
| Darren Cline | 15 |
| Wyche Fowler | 15 |
| Eric Dobmeier | 14 |
| Daniel Hume | 14 |
| Abraham Ceesay | 13 |
| Ronald Bentsur | 13 |
- Stock Market
- Insiders
- Enrique Poradosu
- Company connections
